AVIXGEN INC.
11Patents
11Active
11Granted
48Portfolio score
Filing activity: Dec 20, 2007 → May 17, 2021 · 2 expiring within 5 years
Most-cited patents
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US9969771B2 | Tetrapeptide having effect of inhibiting VEGF-induced angiogenesis and use thereof | Human Necessities | 1 | Active |
| US10149888B2 | Method of inhibiting HIV replication utilizing the P7 nucleocapsid protein | Chemistry; Metallurgy | 0 | Active |
| US11547649B2 | Fusion protein bound to cell-permeable peptide, and composition comprising fusion protein or cell-permeable peptide and epithelial cell growth factor as active ingredients | Emerging Cross-Sectional Technologies | 0 | Active |
| US11040999B2 | Angiogenesis-inhibiting peptide and composition for preventing and treating angiogenesis-related disease comprising same as active ingredient | Human Necessities | 0 | Active |
| US10821101B2 | Pharmaceutical composition for preventing or treating AIDS comprising rhodanine derivative | Human Necessities | 0 | Active |
| US10231971B2 | Pharmaceutical composition for preventing and treating dry eye diseases, containing imatinib as active ingredient | Human Necessities | 0 | Active |
| US9738905B2 | Vector for expressing NC protein of HIV and method for producing NC protein using the same | Chemistry; Metallurgy | 0 | Active |
| US11141407B2 | Pharmaceutical composition for preventing or treating aids comprising rhodanine derivative | Human Necessities | 0 | Active |
| US11702449B2 | Angiogenesis-inhibiting peptide and composition for preventing and treating angiogenesis-related disease comprising same as active ingredient | Human Necessities | 0 | Active |
| US8759536B2 | Rhodanine derivatives, method for preparing same, and pharmaceutical composition for the prevention or treatment of aids containing the rhodanine derivatives as active ingredients | Chemistry; Metallurgy | 0 | Active |
| US11208433B2 | Peptide for inhibiting skin inflammation and composition for preventing or treating skin inflammation containing the same | Human Necessities | 0 | Active |
Source: USPTO / EPO open patent data. Counts and citation impact are objective bibliographic measures.